Salud financiera de hoja de balance de Demant

Salud financiera controles de criterios 3/6

Demant tiene un patrimonio de accionistas total de DKK9.5B y una deuda total de DKK13.1B, lo que sitúa su ratio deuda-patrimonio en 137.5%. Sus activos y pasivos totales son DKK32.4B y DKK22.9B respectivamente. El BAIT de Demant es de DKK4.0B, por lo que su ratio de cobertura de intereses es de 7.8. Tiene efectivo e inversiones a corto plazo que ascienden a DKK1.0B.

Información clave

137.5%

Ratio deuda-patrimonio

DKK 13.10b

Deuda

Ratio de cobertura de intereses	7.8x
Efectivo	DKK 1.05b
Patrimonio	DKK 9.52b
Total pasivo	DKK 22.87b
Activos totales	DKK 32.39b

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (DKK10.7B) de DEMANC superan a sus pasivos a corto plazo (DKK7.5B).

Pasivo a largo plazo: Los activos a corto plazo (DKK10.7B) de DEMANC no cubren sus pasivos a largo plazo (DKK15.4B).

Historial y análisis de deuda-patrimonio

Nivel de deuda: La relación deuda neta-capital de DEMANC (126.5%) se considera alta.

Reducción de la deuda: El ratio deuda-patrimonio de DEMANC ha crecido de 95.3% a 137.5% en los últimos 5 años.

Cobertura de la deuda: La deuda de DEMANC está bien cubierta por el flujo de caja operativo (27.8%).

Cobertura de intereses: Los pagos de intereses de la deuda de DEMANC están bien cubiertos por el BAIT (7.8x cobertura).

Salud financiera de hoja de balance de Demant

Salud financiera controles de criterios 3/6

Información clave

Actualizaciones recientes sobre salud financiera

Recent updates

Demant A/S Appoints Anne-Karen Hunt as President of Diagnostics Business Area, Effective 1 November 2024

Demant A/S Announces Board Changes

Demant A/S Updates Earnings Guidance for the Year 2024

Cochlear Limited (ASX:COH) acquired Oticon Medical A/s from Demant A/S (CPSE:DEMANT).

Cochlear Limited (ASX:COH) acquired Oticon Medical A/s from Demant A/S (CPSE:DEMANT).

Less than half of directors are independent

Demant A/S Provides Earnings Guidance for the Year 2024

Investor sentiment improves as stock rises 21%

Anja Madsen Announces Not to Stand for Re-Election to the Board of Directors of Demant A/S

Less than half of directors are independent

Demant A/S to Report Nine Months, 2024 Results on Nov 04, 2024

Less than half of directors are independent

Demant A/S Provides Earnings Guidance for the Year 2023

Less than half of directors are independent

Now 21% undervalued

Demant A/S Announces Executive Changes

Less than half of directors are independent

Investor sentiment improves as stock rises 16%

Less than half of directors are independent

Now 22% undervalued

Less than half of directors are independent

Less than half of directors are independent

Demant A/S to Report Fiscal Year 2022 Results on Feb 07, 2023

Less than half of directors are independent

Demant A/S Revised Earnings Guidance for the Full Year of 2022

Less than half of directors are independent

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Demant A/S Revises Earnings Guidance for the Full Year 2022

Less than half of directors are independent

Less than half of directors are independent

Demant A/S (CPSE:DEMANT) acquired remaining 80% interest in ShengWang for CNY.

Less than half of directors are independent

Demant A/S Appoints Niels Wagner to the Board of Directors

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Less than half of directors are independent

Demant A/S Announces Update on Voluntary Field Corrective Action

Less than half of directors are independent

Demant A/Sreiterated Guidance for the Year 2021

Less than half of directors are independent

Less than half of directors are independent

Demant A/S Updates Earnings Guidance for the Year 2021

Independent Director has left the company

Independent Director has left the company

New 90-day high: kr.263

Full year 2020 earnings released: EPS kr.4.68 (vs kr.6.00 in FY 2019)

Revenue beats expectations

Demant A/S Announces Executive Changes

New 90-day high: kr.237

Demant Launches New Flagship Hearing aids

New 90-day high: kr.235

Demant A/S, Annual General Meeting, Mar 05, 2021

Demant A/S Revises Earnings Guidance for the Second Half of Fiscal Year 2020

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Descubre empresas con salud financiera